613.78
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$618.43
Offen:
$608.58
24-Stunden-Volumen:
1.20M
Relative Volume:
0.61
Marktkapitalisierung:
$226.94B
Einnahmen:
$45.20B
Nettoeinkommen (Verlust:
$6.87B
KGV:
33.74
EPS:
18.1888
Netto-Cashflow:
$6.75B
1W Leistung:
-1.35%
1M Leistung:
+8.68%
6M Leistung:
+19.72%
1J Leistung:
+25.39%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, IQV, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | DZ Bank | Buy |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
Thermo Fisher Scientific (NYSE:TMO) Shows Strong Technical Breakout Setup - ChartMill
Thermo Fisher CEO: ‘Society broadly embraces the breakthroughs’ - Financial Times
Thermo Fisher stock trades near consensus target as guidance supports outlook - AD HOC NEWS
Should You Continue to Hold TMO Stock in Your Portfolio? - TradingView
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Baird Adjusts Price Target on Thermo Fisher Scientific to $686 From $652, Keeps Outperform Rating - marketscreener.com
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis - Business Wire
Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch
Thermo Fisher (NYSE: TMO) insider uses stock to cover taxes instead of selling on market - Stock Titan
Thermo Fisher Scientific (NYSE: TMO) CEO uses shares to cover taxes and discloses trust holdings - Stock Titan
Thermo Fisher Scientific to Present at the Morgan Stanley 24 - Business Wire
Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis - Yahoo Finance
Thermo Fisher (NYSE: TMO) executive to sell 4,133 shares - Stock Titan
Is Thermo Fisher Scientific Stock Outperforming the Nasdaq? - Yahoo Finance
Thermo Fisher Scientific Inc. (TMO): Investor Outlook with a 1.49% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials Research - BioSpace
Thermo Fisher (NYSE: TMO) CEO exercises options, sells 275 shares - Stock Titan
Here's How Much $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today - Benzinga
Thermo Fisher Scientific Launches First Orbitrap Mass Spectrometers for Isotope Ratio Analysis, Enabling More Labs to Decode the Story Behind a Sample - BioSpace
Thermo Fisher Scientific(TMO.US) Officer Sells US$12.56 Million in Common Stock - Moomoo
Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress - Yahoo Finance
Thermo Fisher (NYSE: TMO) holder Marc Casper plans another stock sale - Stock Titan
Portfolio Design Labs LLC Takes $1.53 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
4,241 Shares in Thermo Fisher Scientific Inc. $TMO Acquired by Silvant Capital Management LLC - MarketBeat
Trillium Asset Management LLC Purchases Shares of 31,849 Thermo Fisher Scientific Inc. $TMO - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Invests $2 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
6,477 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by one8zero8 LLC - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
William O'Neil Initiates Thermo Fisher Scientific at Buy - marketscreener.com
E Fund Management Co. Ltd. Invests $1.37 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fairtree Asset Management Pty Ltd Invests $2.96 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher (TMO) Insider Sell: Sr. VP and Chief HR Officer Li - GuruFocus
2,646 Shares in Thermo Fisher Scientific Inc. $TMO Acquired by Csenge Advisory Group - MarketBeat
CM Wealth Advisors LLC Buys New Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Lisa Britt Sells 11,440 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
Advisors Capital Management LLC Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Bank of New York Mellon Corp Invests $1.97 Billion in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Advisors Preferred LLC Acquires New Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific's Chief HR Officer Reports Stock Option Exercise and Share Sale - Kalkine Media
Marc Casper lines up another Thermo Fisher (NYSE: TMO) stock sale - Stock Titan
Thermo Fisher (TMO) HR leader exercises options, sells stock - Stock Titan
Accelerating KOL Reach and Impact at Thermo Fisher Scientific - Veeva
Why Thermo Fisher Scientific (TMO) Stock Is Up Today - Quiver Quantitative
Thermo Fisher Scientific (NYSE:TMO) Gains Fresh Market Attention - Kalkine Media
Kentucky Farm Bureau Mutual Insurance Co Takes Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Mmbg Investment Advisors CO. Makes New $7.08 Million Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
NewEdge Wealth LLC Invests $5.36 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):